Evidence map›Paper›PMID 41405736›Full record

ArticleJournal of molecular modeling2025

Tuning the band gap and optical characteristics of NiO nanoparticles via tin (Sn) doping: a combined experimental and DFT investigation.

Habtamu F Etefa, Francis B Dejene

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Habtamu F EtefaDepartment of Physics, Walter Sisulu University, Private Bag X-1, Mthatha, 5117, South Africa. habtamufekadu24@gmail.com.
Francis B DejeneDepartment of Physics, Walter Sisulu University, Private Bag X-1, Mthatha, 5117, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe structural and electronic modifications induced by tin (Sn) doping in cubic nickel oxide (NiO) were investigated through a combined computational and experimental approach. Sn incorporation into the NiO lattice is of significant interest for tailoring its optoelectronic properties toward enhanced energy conversion and photocatalytic applications. Experimentally synthesized NiO nanoparticles confirmed the theoretical predictions, showing that increasing Sn concentration (0-12.5%) leads to lattice distortion and bandgap narrowing. The observed bandgap reduction, from 2.89 eV (pure NiO) to 2.56 eV (12.5% Sn-NiO), was attributed to a Fermi level shift and the introduction of defect states, demonstrating that Sn doping effectively tunes the electronic structure of NiO.

methodsTheoretical investigations were conducted using spin-polarized density functional theory with Hubbard correction (DFT + U) within the Quantum ESPRESSO (v7.2) framework to elucidate the electronic properties. The cubic NiO (a = 4.22 Å) was modeled with a 2 × 2 × 2 supercell using the Perdew-Burke-Ernzerhof (PBE) functional under generalized gradient approximation (GGA) and ultrasoft pseudopotentials from PSLibrary 1.0.0. Convergence tests yielded cutoffs of 50 Ry (wavefunction) and 400 Ry (charge density) with a 7 × 7 × 7 Monkhorst-Pack grid. A Hubbard U of 6.0 eV was applied to Ni 3d orbitals to correct correlation effects. Sn doping (3.125-12.5%) was introduced by substituting Ni atoms, and all structures were optimized using the Broyden-Fletcher-Goldfarb-Shanno (BFGS) algorithm. Electronic band structures and density of states (DOS) were calculated along high-symmetry paths to analyze the doping-induced modifications in NiO's electronic properties.

Indexed as

DFTNiOOptical propertiesSn doping

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.